Outcomes | Illustrative comparative risksa (95 % CI) | Relative effect (95 % CI) | No of Participants (studies) | Quality of the evidence (GRADE) | Comments | |
---|---|---|---|---|---|---|
Assumed risk | Corresponding risk | |||||
Conventional treatment | ShenXiong glucose plus conventional treatment | |||||
Death | none | none | none | none | none | CRITICAL |
NFDS Follow-up: 1–4 weeks | none | The mean NFDS in the intervention groups was -4.70 lower (−6.04 to −3.36 lower) | - | 821 (7 studies) | ⊕ ⊕ ⊕⊝ moderate | CRITICAL |
NFDS - 1 week | none | The mean NFDS - 1 week in the intervention groups was −2.37 lower (−5.44 lower to 0.7 higher) | - | 156 (2 studies) | CRITICAL | |
NFDS - 2 weeks | none | The mean NFDS - 2 weeks in the intervention groups was −5.39 lower (−6.90 to −3.87 lower) | - | 378 (4 studies) | CRITICAL | |
NFDS - 4 weeks | none | The mean NFDS - 4 weeks in the intervention groups was −5.16 lower (−6.49 to −3.83 lower) | - | 287 (4 studies) | CRITICAL | |
Barthel score | none | The mean Barthel score in the intervention groups was 19.98 higher (10.17 to 29.79 higher) | - | 477 (5 studies) | ⊕ ⊕ ⊝⊝ low | CRITICAL |
Barthel score - 1 week Follow-up: mean 1 weeks | none | The mean Barthel score - 1 week in the intervention groups was 4.65 higher (−1.56 lower to 10.86 higher) | - | 70 (1 study) | ⊕ ⊕ ⊕⊝ moderate [2] | CRITICAL |
Barthel score - 2 weeks Follow-up: mean 2 weeks | none | The mean Barthel score - 2 weeks in the intervention groups was 12.14 higher (0.47 to 23.82 higher) | - | 150 (2 studies) | CRITICAL | |
Barthel score - 4 weeks Follow-up: mean 4 weeks | none | The mean Barthel score - 4 weeks in the intervention groups was 28.09 higher (15.12 to 41.07 higher) | - | 257 (4 studies) | CRITICAL | |
Response rate Follow-up: mean 4 weeks | Study population | RR 1.17 (1.1 to 1.24) | 880 (11 studies) | ⊕ ⊕ ⊕⊝ moderate [10] | IMPORTANT | |
736 per 1000 | 861 per 1000 (810 to 913) | |||||
Moderate | ||||||
750 per 1000 | 878 per 1000 (825 to 930) |